Safety and efficacy of bromodomain and extra-terminal inhibitors for the treatment of hematological malignancies and solid tumors: a systematic study of clinical trials

Y Sun, J Han, Z Wang, X Li, Y Sun, Z Hu - Frontiers in pharmacology, 2021 - frontiersin.org
Background: The upregulated expression of BET proteins is closely associated with the
occurrence and development of hematological malignancies and solid tumors. Several BET …

Clinical manifestations and epigenetic regulation of oral herpesvirus infections

N Atyeo, MD Rodriguez, B Papp, Z Toth - Viruses, 2021 - mdpi.com
The oral cavity is often the first site where viruses interact with the human body. The oral
epithelium is a major site of viral entry, replication and spread to other cell types, where …

Discovery of novel phenoxyaryl pyridones as bromodomain and extra-terminal domain (BET) inhibitors with high selectivity for the second bromodomain (BD2) to …

W Jiang, Q Hou, H Xu, K Yang, X Wang… - Journal of Medicinal …, 2024 - ACS Publications
Bromodomain-selective BET inhibition has emerged as a promising strategy to improve the
safety profiles of pan-BET inhibitors. Herein, we report the discovery of potent phenoxyaryl …

Discovery of a novel bromodomain and extra terminal domain (BET) protein inhibitor, I-BET282E, suitable for clinical progression

KL Jones, DM Beaumont, SG Bernard… - Journal of Medicinal …, 2021 - ACS Publications
The functions of the bromodomain and extra terminal (BET) family of proteins have been
implicated in a wide range of diseases, particularly in the oncology and immuno …

Overview of antiviral drug discovery and development: viral versus host targets

G Li, E De Clercq - 2021 - books.rsc.org
During recent decades, a great variety of viral and host targets have been exploited for the
discovery of antiviral agents against human infectious diseases. 1 Although significant …

Targeting BRD4: Potential therapeutic strategy for head and neck squamous cell carcinoma

V Yongprayoon, N Wattanakul… - Oncology …, 2024 - spandidos-publications.com
As a member of BET (bromodomain and extra-terminal) protein family, BRD4 (bromodomain-
containing protein 4) is a chromatin-associated protein that interacts with acetylated histones …

[HTML][HTML] Viral hijacking of BET proteins

IP Chen, M Ott - Viruses, 2022 - mdpi.com
Proteins of the bromodomain and exterminal domain (BET) family mediate critical host
functions such as cell proliferation, transcriptional regulation, and the innate immune …

Identification of a Series of N-Methylpyridine-2-carboxamides as Potent and Selective Inhibitors of the Second Bromodomain (BD2) of the Bromo and Extra Terminal …

LA Harrison, SJ Atkinson, A Bassil… - Journal of Medicinal …, 2021 - ACS Publications
Domain-specific BET bromodomain ligands represent an attractive target for drug discovery
with the potential to unlock the therapeutic benefits of antagonizing these proteins without …

Multiple roles of Brd4 in the infectious cycle of human papillomaviruses

AA McBride, A Warburton, S Khurana - Frontiers in Molecular …, 2021 - frontiersin.org
Human Papillomaviruses (HPV) reproduce in stratified epithelia by establishing a reservoir
of low-level infection in the dividing basal cells and restricting the production of viral particles …

[HTML][HTML] Viral manipulation of the host epigenome as a driver of virus-induced oncogenesis

SHAA Soliman, A Orlacchio, F Verginelli - Microorganisms, 2021 - mdpi.com
Tumorigenesis due to viral infection accounts for a high fraction of the total global cancer
burden (15–20%) of all human cancers. A comprehensive understanding of the mechanisms …